you are viewing a single comment's thread.
Max I believe these are the 4 drugs with data points at Ash:SGI-110AmuvatinibAt13387 HSP90 InhibitorAT9283 JAK/Aurora Inhibitor MM and a seperate Ped. leukemiaThe AT13148 trial is a ph1Other trials are with partners and that news stays with them.I remember we use to have to wait on Supg, so they could tell us how they need to reformulate. These delays were usually 2 years.I believe ASTX was a very smart move.
AT 13148 is one to keep an eye on also. Really interesting. Got a decent write-up in a British newspaper.
You getting lazy max? Here is link:http://www.pharmatimes.com/article/12-07-12/New_hope_for_broad_spectrum_cancer_drug.aspx